CLINICAL TRIALS PROFILE FOR LIPOSYN II 10%

All Clinical Trials for LIPOSYN II 10%

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00002029 ↗	Long-Term Nutritional Support in Patients With the Acquired Immunodeficiency Syndrome: Comparison of Liposyn III 2 Percent With Liposyn II 20 Percent	Completed	Abbott	N/A	1969-12-31	To compare two lipid emulsions in the long-term parenteral alimentation of patients with AIDS in relation to: Clinical effectiveness. Effect on immunologic function. Effect on HIV load as measured by p24 antigen levels. Effect on relative HIV infectivity.
NCT00002275 ↗	A Comparison of Two Types of Injected Nutritional Supplements in Patients With AIDS and Pneumocystis Carinii Pneumonia (PCP)	Completed	Abbott	N/A	1969-12-31	The objectives of this study are: To establish whether there is a difference in clinical effectiveness of Liposyn II 20 percent as compared with Liposyn III 2 percent in AIDS patients with Pneumocystis carinii pneumonia (PCP). To compare the effects of the two lipid emulsions on immunologic function in AIDS patients. To compare the effect of the two lipid emulsions on HIV load in AIDS patients as measured by reverse transcriptase (RT) in culture. To determine whether a decrease in HIV infectivity is greater in patients given a parenteral feeding regimen containing Liposyn II 20 percent or Liposyn III 2 percent.
NCT01740817 ↗	A Study to Evaluate the Effect of Lipid Infusion on Toll Like Receptor 4 (TLR4) Signaling	Completed	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	N/A	2008-01-01	The purpose of this study is to determine whether a lipid infusion can up-regulate toll-like receptor 4 (TLR4) signaling in human subjects
NCT01740817 ↗	A Study to Evaluate the Effect of Lipid Infusion on Toll Like Receptor 4 (TLR4) Signaling	Completed	The University of Texas Health Science Center at San Antonio	N/A	2008-01-01	The purpose of this study is to determine whether a lipid infusion can up-regulate toll-like receptor 4 (TLR4) signaling in human subjects

Clinical Trial Conditions for LIPOSYN II 10%

Condition Name

Condition Name for LIPOSYN II 10%
Intervention	Trials
HIV Infections	2
Diabetes	1
Insulin Resistance	1
Obesity	1

Condition MeSH

Condition MeSH for LIPOSYN II 10%
Intervention	Trials
Immunologic Deficiency Syndromes	2
HIV Infections	2
Acquired Immunodeficiency Syndrome	2
Insulin Resistance	1

Clinical Trial Locations for LIPOSYN II 10%

Trials by Country

Trials by Country for LIPOSYN II 10%
Location	Trials
United States	6

Trials by US State

Trials by US State for LIPOSYN II 10%
Location	Trials
New Jersey	2
Ohio	1
Louisiana	1
Texas	1
Florida	1

Clinical Trial Progress for LIPOSYN II 10%

Clinical Trial Phase

Clinical Trial Phase for LIPOSYN II 10%
Clinical Trial Phase	Trials
N/A	3
Early Phase 1	1

Clinical Trial Status

Clinical Trial Status for LIPOSYN II 10%
Clinical Trial Phase	Trials
Completed	4

Clinical Trial Sponsors for LIPOSYN II 10%

Sponsor Name

Sponsor Name for LIPOSYN II 10%
Sponsor	Trials
Abbott	2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	1
The University of Texas Health Science Center at San Antonio	1

Sponsor Type

Sponsor Type for LIPOSYN II 10%
Sponsor	Trials
Other	3
Industry	2
NIH	1